This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2006 May;147(5):211-9.

doi: 10.1016/j.lab.2005.12.006.

Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications

Margo P Cohen¹, Fuad N Ziyadeh, Sheldon Chen

Affiliations

PMID: 16697768
PMCID: PMC1800931
DOI: 10.1016/j.lab.2005.12.006

Review

Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications

Margo P Cohen et al. J Lab Clin Med. 2006 May.

. 2006 May;147(5):211-9.

doi: 10.1016/j.lab.2005.12.006.

Authors

Margo P Cohen¹, Fuad N Ziyadeh, Sheldon Chen

Affiliation

¹ University City Science Center, Philadelphia, Pennsylvania, USA. drmpcohen@aol.com

PMID: 16697768
PMCID: PMC1800931
DOI: 10.1016/j.lab.2005.12.006

No abstract available

PubMed Disclaimer

Similar articles

Glycated Serum Albumin and AGE Receptors.
Vetter SW. Vetter SW. Adv Clin Chem. 2015;72:205-75. doi: 10.1016/bs.acc.2015.07.005. Epub 2015 Sep 19. Adv Clin Chem. 2015. PMID: 26471084 Review.
Pathophysiological role of Amadori-glycated proteins in diabetic microangiopathy.
Schalkwijk CG, Lieuw-a-Fa M, van Hinsbergh VW, Stehouwer CD. Schalkwijk CG, et al. Semin Vasc Med. 2002 May;2(2):191-7. doi: 10.1055/s-2002-32042. Semin Vasc Med. 2002. PMID: 16222610 Review.
Glycated serum albumin: a potential disease marker and an intermediate index of diabetes control.
Raghav A, Ahmad J. Raghav A, et al. Diabetes Metab Syndr. 2014 Oct-Dec;8(4):245-51. doi: 10.1016/j.dsx.2014.09.017. Epub 2014 Oct 11. Diabetes Metab Syndr. 2014. PMID: 25311816 Review.
Minimizing spurious receptor-binding kinetics with modified proteins.
Shaw SM, Crabbe MJ. Shaw SM, et al. Anal Biochem. 1994 May 15;219(1):161-3. doi: 10.1006/abio.1994.1249. Anal Biochem. 1994. PMID: 8059947 No abstract available.
Alpha-lipoate can protect against glycation of serum albumin, but not low density lipoprotein.
Kawabata T, Packer L. Kawabata T, et al. Biochem Biophys Res Commun. 1994 Aug 30;203(1):99-104. doi: 10.1006/bbrc.1994.2154. Biochem Biophys Res Commun. 1994. PMID: 8074733

See all similar articles

Cited by

Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion.
Shen Y, Lu L, Ding FH, Sun Z, Zhang RY, Zhang Q, Yang ZK, Hu J, Chen QJ, Shen WF. Shen Y, et al. Cardiovasc Diabetol. 2013 Nov 8;12:165. doi: 10.1186/1475-2840-12-165. Cardiovasc Diabetol. 2013. PMID: 24209601 Free PMC article.
Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats.
Lu L, Peng WH, Wang W, Wang LJ, Chen QJ, Shen WF. Lu L, et al. J Zhejiang Univ Sci B. 2011 Aug;12(8):652-9. doi: 10.1631/jzus.B1101004. J Zhejiang Univ Sci B. 2011. PMID: 21796806 Free PMC article.
Glycated Albumin is Independently Associated With Arterial Stiffness in Non-Diabetic Chronic Kidney Disease Patients.
Choi HY, Park SK, Yun GY, Choi AR, Lee JE, Ha SK, Park HC. Choi HY, et al. Medicine (Baltimore). 2016 Apr;95(16):e3362. doi: 10.1097/MD.0000000000003362. Medicine (Baltimore). 2016. PMID: 27100419 Free PMC article.
Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases.
Cepas V, Collino M, Mayo JC, Sainz RM. Cepas V, et al. Antioxidants (Basel). 2020 Feb 6;9(2):142. doi: 10.3390/antiox9020142. Antioxidants (Basel). 2020. PMID: 32041293 Free PMC article. Review.
Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.
Dostalek M, Akhlaghi F, Puzanovova M. Dostalek M, et al. Clin Pharmacokinet. 2012 Aug 1;51(8):481-99. doi: 10.2165/11631900-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22668340 Review.

See all "Cited by" articles

References

1. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. New Engl J Med. 2005;352:1685–1695. - PubMed
1. Jaleel A, Halvatsiotis P, Williamson B, Juhasz P, Martin S, Nair KS. Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment. Diabetes Care. 2005;28:645–652. - PubMed
1. Eriksson EE, Xie X, Werr J, Thoren P, Lindbom L. Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med. 2001;194:205–218. - PMC - PubMed
1. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 1998;2:275–281. - PubMed
1. Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res. 2004;94:253–261. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information